M4MM
Ascend Wellness Seeks Shareholder Approval for Reverse Stock Split Ahead of Potential Uplisting
NEW YORK – Ascend Wellness Holdings Inc., a vertically integrated multistate Cannabis operator, is preparing for a possible move to a major U.S. stock exchange. The company has filed documents outlining a shareholder vote on ...
The Real Operational Cost of Cash Discrepancies in High-Volume Dispensaries
LOS ANGELES – Cannabis dispensaries occupy a distinctive position in American retail. They are among the highest-grossing single-location stores in the country, processing thousands of transactions per day, yet the majority remain locked out of ...
Psychedelic Alpha Partners with Horizons to Present The Psychedelic Business Forum
NEW YORK – The Psychedelic Business Forum, Horizons: Perspectives on Psychedelics, returns to the New York Academy of Medicine on October 15, 2026, with Psychedelic Alpha formalized this year as a co-presenter alongside Horizons. Horizons ...
North Carolina Lawmakers Unite Behind Psychedelic Research Bill for Veterans
RALEIGH – NC Lawmakers from both parties held a press conference at the General Assembly to support legislation that would direct state funding toward research on psilocybin, MDMA, and ibogaine as treatments for PTSD and ...
Glass House Brands Applies for NYSE Uplisting
LONG BEACH – Glass House Brands Inc., a vertically integrated Cannabis company concentrated in California, announced it has applied to list its subordinate voting shares on the New York Stock Exchange. The filing is among ...
Virginia Governor and Lawmakers Announce Agreement on Legal Cannabis Sales
RICHMOND – Governor Abigail Spanberger, State Senator Lashrecse Aird (D), and Delegate Paul Krizek (D), announced they had reached a compromise to establish a legal, regulated retail cannabis market. This marks the culmination of a ...
Splash Beverage Group Completes Strategic Investment in Avicanna, Transforms into Cannabinoid Healthcare
FORT LAUDERDALE – Splash Beverage Group Inc. announced the completion of a CDN$300,000 (~USD$217,479) minority investment in Avicanna Inc., a commercial-stage international biopharmaceutical company headquartered in Toronto, Canada. The transaction involved Splash acquiring 2,000,000 common ...
Ascend Wellness Seeks Shareholder Approval for Reverse Stock Split Ahead of Potential Uplisting
NEW YORK – Ascend Wellness Holdings Inc., a vertically integrated multistate Cannabis operator, is preparing for a possible move to a major U.S. stock exchange. The company has filed documents outlining a shareholder vote on ...
The Real Operational Cost of Cash Discrepancies in High-Volume Dispensaries
LOS ANGELES – Cannabis dispensaries occupy a distinctive position in American retail. They are among the highest-grossing single-location stores in the country, processing thousands of transactions per day, yet the majority remain locked out of ...
Psychedelic Alpha Partners with Horizons to Present The Psychedelic Business Forum
NEW YORK – The Psychedelic Business Forum, Horizons: Perspectives on Psychedelics, returns to the New York Academy of Medicine on October 15, 2026, with Psychedelic Alpha formalized this year as a co-presenter alongside Horizons. Horizons ...
Sensi Brands Secures Major Cultivation Site in Bid for Overseas Expansion
RICHMOND HILL – Sensi Brands Inc. completed its purchase of Maricann Inc., gaining control of a sprawling production facility tailored for export markets. The deal, the company's biggest to date, centers on a 100-acre campus ...
High Tide Launches Europe’s First Canna Cabana Store in Berlin
BERLIN – High Tide Inc., the Calgary-based Cannabis retailer known for its discount club model, has cut the ribbon on its inaugural European outpost, a Canna Cabana store in central Berlin that sells accessories and ...
Conservative Think Tank Advocates Federal Cannabis Labeling Standards to Address State Disparities
WASHINGTON – A prominent conservative policy group has called for federal guidance on Cannabis product warnings, pointing to stark differences in state regulations that leave consumers with inconsistent information on health risks. The American Enterprise ...
Psyence BioMed Ventures into Psilocybin’s Role in Aging Research
NEW YORK – Psyence BioMedical Ltd. disclosed its entry into longevity science with a new program probing psilocybin's influence on key aging indicators. The initiative, conducted alongside South African academics, marks the company's first foray ...
Kenyan MP Advocates for Regulated Cannabis Framework
NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the ...
OPINION: The Looming Federal Clampdown on THC Drinks and Hemp-Derived Edibles: What It Means for the Industry
NEW YORK- The quiet addition of a single paragraph in November’s federal shutdown bill has sent shockwaves through one of the fastest-growing segments of U.S. Cannabis: hemp-derived THC beverages and edibles. Unless Congress intervenes, a ...
Tilray Executes 1-for-10 Reverse Stock Split to Trim Shares and Cut Costs
NEW YORK – Tilray Brands Inc. confirmed it will carry out a 1-for-10 reverse stock split on its common shares, a step shareholders greenlit back in June to help the company meet Nasdaq listing standards ...
New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients
ALBANY – Governor Kathy Hochul signed a bill into law that extends New York's medical Cannabis program to patients certified in other states, marking the most substantial revision to the initiative since its 2016 launch. ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program
TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
